As a cardiologist, Topol has always championed aerobic exercise to reduce the risk of heart disease. Since studying the ...

The blood test measures two subtypes of tau and amyloid proteins, which can indicate the presence of amyloid plaque in the ...

The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test detects signs of amyloid plaque build-up in the brain.

The blood test measures two subtypes of tau and amyloid proteins, which can indicate the presence of amyloid plaque in the ...

A new study presented at COMy 2025 reveals that patients with amyloid light-chain amyloidosis still face significant delays ...

PITTSBURGH — Earlier this month, the FDA approved another biomarker to help millions of patients and families affected by ...

The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and ...

In a new study published in Cell Genomics, researchers use RNA sequencing to characterize bone metastases from eight cancer ...

The extent of myocardial bone tracer uptake with technetium pyrophosphate, hydroxymethylene diphosphonate, and 3,3-diphosphono-1,2-propanodicarboxylate in transthyretin amyloid cardiomyopathy (ATTR-CM ...

AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.

scans taken originally to look for tumors or bleeding or infections, also revealed calcium buildup in arteries, a sign of worsening ... How Breast Cancer Cells Survive in Bone Marrow After ...

The status has been given to the B7-H3-targeted drug as a treatment for late-line relapsed or refractory osteosarcoma, a rare form of bone cancer with no FDA-approved treatments. The coveted ...